Related Experiment Video
Updated: Mar 21, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Coeliac disease in patients with short stature: A tertiary care centre experience
Prashant Singh1, Piyush Kumar Sharma1, Abhishek Agnihotri1
1Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
Insights
Approximately 11% of children with short stature have coeliac disease. Chronic diarrhoea and anaemia are key predictors, with significant growth improvement on a gluten-free diet.
Area of Science:
- Paediatric Endocrinology
- Gastroenterology
- Genetics
Background:
- Short stature affects a significant number of children, with diverse underlying causes.
- Coeliac disease, an autoimmune disorder triggered by gluten, can manifest with growth impairment.
Purpose of the Study:
- To determine the prevalence of coeliac disease in children with short stature.
- To identify predictors of coeliac disease in this pediatric population.
Main Methods:
- Retrospective review of 432 children with short stature evaluated between 2008-2011.
- Screening for coeliac disease using IgA-anti-tissue transglutaminase antibody.
- Diagnosis confirmed using modified European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) criteria.
Main Results:
- Coeliac disease was diagnosed in 10.9% of children with short stature.
- Chronic diarrhoea (OR 15.7) and anaemia (OR 4.9) were significant predictors.
- Patients showed improved growth velocity (8.1 cm/year) on a gluten-free diet.
Conclusions:
- Coeliac disease is a notable cause of short stature in children.
- Screening for coeliac disease is recommended in children with short stature, particularly those with chronic diarrhoea or anaemia.
- A gluten-free diet effectively improves growth in affected children.
Background:
We aimed to determine the prevalence of coeliac disease among children with short stature at a tertiary care centre and to define the predictors for coeliac disease, if any, in them.
Methods:
In this retrospective study, we reviewed the case records of children and adolescents with growth retardation attending the Paediatric Endocrinology Clinic from January 2008 to June 2011. All patients underwent the multi-tier stratified diagnostic protocol for complete evaluation of short stature. Coeliac disease was screened using IgA-anti-tissue transglutaminase antibody. The diagnosis of coeliac disease was made on the basis of the modified European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) criteria.
Results:
Of 432 patients (238 boys) who presented with short stature, 72 (16.7%) had physiological, while 360 (83.3%) had pathological causes. Endocrine causes were growth hormone deficiency (86 patients, 19.9%), hypopituitarism (31, 7.2%), hypothyroidism (22, 5.1%) and others (7, 1.6%). The systemic causes were: coeliac disease (47, 10.9%), haematological diseases (14, 3.2%), renal diseases (11, 2.5%) and others (24, 5.6%). Chronic diarrhoea (OR 15.7, 95% CI 7.8-31.5) and anaemia (OR 4.9, 95% CI 1.9-12.7]) were significant predictors for coeliac disease in patients with short stature. There was a definite response to gluten-free diet in them and the mean (SD) growth velocity measured over at least 6 months of gluten-free diet was 8.1 (3.0) cm/year.
Conclusion:
Nearly 11% of patients presenting with short stature have coeliac disease. In these patients chronic diarrhoea and anaemia were significant predictors of coeliac disease.
Related Concept Videos
Nature and Nurture
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Signs of Puberty
Inborn Errors of Metabolism
Chronic Kidney Disease II: Clinical Manifestations

